G. Rice

Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer

Nuzhat Ahmed, M. Quinn, N. Ahmed, 2005, Proteomics.

Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas

G. Rice, M. Quinn, M. Baker, 2003, Molecular carcinogenesis.

Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point‐of‐care test for epithelial ovarian cancer: an observational study

M. Salto‐Tellez, M. Choolani, N. Kothandaraman, 2018, BJOG : an international journal of obstetrics and gynaecology.

Identification of ovarian cancer‐associated proteins in symptomatic women: A novel method for semi‐quantitative plasma proteomics

K. Oliva, G. Barker, M. Ayhan, 2012, Proteomics. Clinical applications.

Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells

M. Quinn, M. Baker, I. Campbell, 2006, Molecular carcinogenesis.

Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer

G. Rice, M. Quinn, B. Kemp, 2004, British Journal of Cancer.

Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex in colon cancer cells

G Rice, G. Rice, M. Quinn, 2003, British Journal of Cancer.

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma

G. Rice, M. Quinn, C. Riley, 2004, British Journal of Cancer.